The Conversation (0)
FinCanna (CSE:CALI) has been featured in an article published by CannabisFN (CFN) Media Group regarding the company’s flagship investment in Cultivation Technologies Inc (CTI) and how it’s uniquely position in generating near term revenue.
FinCanna (CSE:CALI) has been featured in an article published by CannabisFN (CFN) Media Group regarding the company’s flagship investment in Cultivation Technologies Inc (CTI) and how it’s uniquely position in generating near term revenue. The article describes FinCanna as a “royalty company that’s focused on building a portfolio of investments in scalable, best-in-class projects in the licensed medical cannabis sector.”
The article talked about the recently launched interim medical cannabis extraction facility in advance to the permanent one in Coachella, California. The article further addressed the new regulations placed in California which increases CTI’s production capacity from 20 percent to 100 percent.
“As revenues from the extraction and manufacturing business are now expected to be the largest segment of CTI’s Coachella Campus, the increase in expected royalties to FinCanna are very significant. We continue to be impressed by CTI’s exceptional management team and support their strategic approach to the market,” said Fincanna CEO Andriyako Herchak.
Lastly, the article discussed the company’s long term ambitions to fund a variety of licensed medical cannabis operations in exchange for an ongoing royalty over time and looking ahead how is the company a unique investment opportunity for investors.
To read the full article, click here.
Click here to connect with FinCanna (CSE:CALI) for an Investor Presentation
Source: www.cannabisfn.com
